Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 37,417 | 38,783 | 37,344 | 32,198 | 29,478 |
| Cost of Goods | 7,194 | 7,446 | 6,786 | 6,279 | 5,551 |
| Gross Profit | 30,223 | 31,337 | 30,558 | 25,919 | 23,927 |
| Operating Expenses | 24,485 | 28,222 | 28,402 | 23,965 | 23,712 |
| Operating Income | 5,932 | 3,561 | 2,942 | 2,233 | 766 |
| Other Income | -8 | -6 | -14 | 1,054 | 60 |
| Pre-tax Income | 5,924 | 3,555 | 2,928 | 3,287 | 826 |
| Income Tax | 455 | 436 | 361 | 366 | 225 |
| Net Income Continuous | 5,469 | 3,119 | 2,567 | 2,921 | 601 |
| Net Income | $5,469 | $3,119 | $2,567 | $2,921 | $601 |
| EPS Basic Total Ops | 0.14 | 0.08 | 0.06 | 0.08 | 0.02 |
| EPS Basic Continuous Ops | 0.14 | 0.08 | 0.07 | 0.08 | 0.02 |
| EPS Diluted Total Ops | 0.13 | 0.08 | 0.07 | 0.07 | 0.02 |
| EPS Diluted Continuous Ops | 0.13 | 0.08 | 0.07 | 0.07 | 0.02 |
| EBITDA(a) | $6,539 | $4,403 | $4,195 | $3,191 | $1,845 |